Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Cancer × pazopanib × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 22 Sarcoma 17 Neoplasms 8 Breast Neoplasms 8 Neoplasm Metastasis 7 Ovarian Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Hemangiosarcoma 5 Fallopian Tube Neoplasms 5 Lung Neoplasms 4 Liposarcoma 4 Leiomyosarcoma 4 Kidney Neoplasms 4 Urinary Bladder Neoplasms 3 Sarcoma, Synovial 3 Neurofibrosarcoma 3 Histiocytoma, Malignant Fibrous 3 Sarcoma, Alveolar Soft Part 2 Recurrence 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neuroendocrine Tumors 2 Melanoma 2 Gliosarcoma 2 Glioblastoma 2 Fibrosarcoma 2 Clear-cell metastatic renal cell carcinoma 2 Chondrosarcoma, Extraskeletal Myxoid 2 Carcinoma, Ovarian Epithelial 2 Brain Neoplasms 2

Interventions

Nivolumab 7 linrodostat 3 Ipilimumab 3 relatlimab 2 Pemetrexed 2 tislelizumab 1 regorafenib 1 ralimetinib 1 p38 Mitogen-Activated Protein Kinases 1 figitumumab 1 efatutazone 1 abemaciclib 1 Vorinostat 1 Tamoxifen 1 Sunitinib 1 Ranitidine 1 Midazolam 1 LY2603618 1 LY2584702 1 Gemcitabine 1 Fulvestrant 1 Dasatinib 1 Crizotinib 1 Cetuximab 1 Carboplatin 1 BMS-813160 1 3-(9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡